Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
177
currently held
Exits tracked
73
hand-checked
Sectors covered
36
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin242 companies matching · Page 1 of 5
Soleno Therapeutics
Abingworth Bioventures VI
USSector
Biotech
InvestorAbingworth
Entry
2018
Hold
8yr
Exit
2026
to Neurocrine Biosciences
TeachFX
Newfund II
USSector
Software
InvestorNewfund Management
Entry
2017
Hold
9yr
Exit
2026
to McGraw Hill
Vibe
Singular Ventures II
USSector
AdTech
InvestorSingular Capital Partners
Entry
2024
Hold
2yr
Owners
2
Exit
2026
to Walmart
Scorpion Therapeutics
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
5yr
Exit
2025
to Eli Lilly
Agathos
Newfund II
USSector
HealthTech
InvestorNewfund Management
Entry
2018
Hold
7yr
Exit
2025
to EvidenceCare
Digg
White Star Capital Fund I
USSector
TMT
InvestorWhite Star Capital
Entry
2014
Hold
11yr
Exit
2025
to Kevin Rose + Alexis Ohanian (True Ventures + Seven Seven Six)
HilleVax
Abingworth Bioventures 8
USSector
Healthcare
InvestorAbingworth
Entry
2021
Hold
4yr
Exit
2025
to XOMA Royalty
Pachama
Aglaé Ventures
USSector
ClimateTech
InvestorAglaé Management
Entry
2020
Hold
5yr
Exit
2025
to Carbon Direct
SZL
Educapital II
USSector
EdTech
InvestorEducapital
Entry
2023
Hold
2yr
Exit
2025
to Campus
Vantage Discovery
Future Positive I
USSector
Software
InvestorFuture Positive Capital
Entry
2023
Hold
2yr
Exit
2025
to Shopify
Ama Waterways
L Catterton Europe IV
USSector
Hospitality
InvestorL Catterton Europe
Entry
2017
Hold
7yr
Owners
2
Jaggaer
Ardian Co-Investment Fund VI
USSector
TMT
InvestorArdian
Entry
2019
Hold
5yr
Owners
2
Lineage
Direct investment by Peugeot Invest
USSector
Logistics
InvestorPeugeot Invest
Entry
2017
Hold
7yr
Exit
2024
OnKure Therapeutics
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2023
Hold
1yr
Exit
2024
to Reneo Pharmaceuticals, Inc.
Pliant
ALSTIN II
USSector
Fintech
InvestorAlstin Capital
Entry
2019
Hold
6yr
Owners
5
MetaMap
Aglaé Ventures
USSector
Fintech
InvestorAglaé Management
Entry
2020
Hold
4yr
Exit
2024
to Incode Technologies
Nitel
Cinven Seventh Fund
USSector
Telecom
InvestorCinven
Entry
2021
Hold
3yr
Exit
2024
to Comcast Business
Q32 Bio
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
4yr
Exit
2024
to Homology Medicines, Inc.
Yumi
Aglaé Ventures
USSector
Consumer
InvestorAglaé Management
Entry
2019
Hold
4yr
Exit
2023
to Once Upon a Farm
Power
Anthemis Venture Fund I
USSector
Fintech
InvestorAnthemis Group
Entry
2021
Hold
2yr
Exit
2023
to Marqeta
Riva
Newfund II
USSector
Software
InvestorNewfund Management
Entry
2019
Hold
4yr
Exit
2023
to Teal Labs
Tremor Technologies
Anthemis Venture Fund I
USSector
InsurTech
InvestorAnthemis Group
Entry
2019
Hold
4yr
Exit
2023
to W. R. Berkley
WFHomie
Newfund III
USSector
Software
InvestorNewfund Management
Entry
2021
Hold
2yr
Exit
2023
to GoCo
Holberton
Daphni Purple
USSector
Education
InvestorDaphni
Entry
2016
Hold
6yr
Exit
2022
to African Leadership Group
Ivantis
Mérieux Innovation 1
USSector
MedTech
InvestorMerieux Equity Partners
Entry
2017
Hold
5yr
Exit
2022
to Alcon
Podsights
Aglaé Ventures
USSector
AdTech
InvestorAglaé Management
Entry
2021
Hold
1yr
Exit
2022
to Spotify
Redpin Therapeutics
4BIO Ventures II
USSector
Biotech
Investor4Bio Partners
Entry
2020
Hold
2yr
Exit
2022
to Kriya Therapeutics
TARA Biosystems
Mérieux Innovation 1
USSector
Biotech
InvestorMerieux Equity Partners
Entry
2019
Hold
3yr
Exit
2022
to Valo Health
Trov
Anthemis Venture Fund I
USSector
InsurTech
InvestorAnthemis Group
Entry
2017
Hold
5yr
Exit
2022
to Travelers
eFFECTOR Therapeutics
Abingworth Bioventures VI
USSector
Biotech
InvestorAbingworth
Entry
2013
Hold
8yr
Exit
2021
to Locust Walk Acquisition Corp.
Inpria
ALIAD
USSector
Deep Tech
InvestorAliad Venture Capital
Entry
2015
Hold
6yr
Exit
2021
to JSR Corp
Aura Biosciences
Columbus Innvierte Life Science Fund I
USSector
Biotech
InvestorColumbus Venture Partners
Entry
2015
Hold
6yr
Owners
3
Exit
2021
Abexxa Biologics
Boehringer Ingelheim Venture Fund
USSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2016
Hold
5yr
Exit
2021
to Boehringer Ingelheim
CVRx
Ysios BioFund II Innvierte
USSector
MedTech
InvestorYsios Capital Partners
Entry
2013
Hold
8yr
Exit
2021
Jasper Therapeutics
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2019
Hold
2yr
Exit
2021
to Amplitude Healthcare Acquisition Corp.
Vera Therapeutics
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2021
Hold
0yr
Exit
2021
Volara
Newfund II
USSector
Software
InvestorNewfund Management
Entry
2015
Hold
6yr
Exit
2021
to Uniguest
Spruce Biosciences
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
0yr
Exit
2020
Activate
White Star Capital Fund I
USSector
TMT
InvestorWhite Star Capital
Entry
2014
Hold
6yr
Exit
2020
to Impact.com
TWIST Bioscience
Mérieux Innovation 1
USSector
Biotech
InvestorMerieux Equity Partners
Entry
2013
Hold
7yr
Exit
2020
to Nasdaq listing (TWST)
Phathom Pharmaceuticals
Abingworth Bioventures VII
USSector
Healthcare
InvestorAbingworth
Entry
2019
Hold
0yr
Exit
2019
Presence AI
Newfund II
USSector
Software
InvestorNewfund Management
Entry
2016
Hold
3yr
Exit
2019
to Groupon
Echo
MMC Ventures EIS Fund
USSector
HealthTech
InvestorMMC Ventures
Entry
2014
Hold
5yr
Owners
2
Exit
2019
to McKesson UK
Anki
C4 Ventures Fund I
USSector
Consumer
InvestorC4 Ventures Management
Entry
2016
Hold
3yr
Exit
2019
to Digital Dream Labs
Avedro
Abingworth Bioventures VI
USSector
MedTech
InvestorAbingworth
Entry
2014
Hold
5yr
Exit
2019
to Glaukos
Fieldvision
HCVC Hardware Club Fund I
USSector
TMT
InvestorElephants & Ventures / Hardware Club
Entry
2018
Hold
1yr
Exit
2019
to BallerTV
CSP Technologies
Wendel SE
USSector
Industrials
InvestorWendel
Entry
2015
Hold
3yr
Exit
2018
to AptarGroup
Innovista Sensors
PAI Europe VI
USSector
Industrials
InvestorPAI Partners
Entry
2014
Hold
4yr
Exit
2018
to Sensata Technologies
Left Hand Robotics
HCVC Hardware Club Fund I
USSector
Industrials
InvestorElephants & Ventures / Hardware Club
Entry
2017
Hold
1yr
Exit
2018
to Toro Company
Small Tube Products
QCP Buyout Fund III
USSector
Industrials
InvestorQuilvest Capital Partners
Entry
2011
Hold
7yr
Exit
2018
to Waybill